-
Drugs with Patents
-
Expiring <2 Years
-
Next Expiration
-
Revenue at Risk (2yr)
⚠️
Patent Risk
Patent Cliff Timeline
<2yr 2-4yr 4+yr Biologic
All Drug Expirations
Loading...
What this shows: When generic or biosimilar competition can enter the market.
SM Small Molecules — Patents from FDA Orange Book. Generic drugs can launch after patents expire.
Bio Biologics — Based on FDA Purple Book exclusivity and patent data. Actual biosimilar entry may differ due to patents extending beyond exclusivity.